Interleukin-1 receptor antagonist

Rheumatic Disease Clinics of North America

Volumn 24, Issue 3, 1998, Pages 615-628

  Bresnihan, B ^a   Cunnane, G ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CELL ADHESION MOLECULE; CORTICOSTEROID; GOLD SALT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METALLOPROTEINASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; RECOMBINANT PROTEIN;

CELL INFILTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERABILITY; ERYTHEMA; EXPERIMENTAL ANIMAL; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOLOGY; IMMUNOPATHOGENESIS; INJECTION SITE; INTRALESIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; SYNOVIUM; T LYMPHOCYTE;

EID: 0031717240     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70029-6     Document Type: Article

References (70)

1. W.P. Arend Interleukin-1 receptor antagonist: A new member of the interleukin-1 family J Clin Invest 88 1991 1445 1451
2. W.P. Arend Interleukin-1 receptor antagonist Adv Immunol 54 1993 167 227
3. Arend W.P. Dayer J.-M. Cytokines and growth factors Kelley W.N. Harris E.D. Ruddy S. Sledge C.B. Textbook of Rheumatology ed 4 1993 WB Saunders Philadelphia 227 247
4. Arend W.P. Dayer J.-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis Arthritis Rheum 38 1995 151 160
5. W.P. Arend H.G. Welgus R.C. Thompson Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist J Clin Invest 85 1990 1694 1697
6. F. Arnett S. Edworthy D. Bloch The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 3 1988 315 324
7. A.C. Bakker L.A.B. Joosten O.J. Arntz Gene therapy of murine collagen-induced arthritis: Local expression of the human IL-1ra protein prevents onset Arthritis Rheum 40 1997 893 900
8. G. Bandara G.M. Mueller Galea Lauri J. Intra-articular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer Proc Natl Acad Sci U S A 90 1993 10764 10768
9. D.E.H. Barkley M. Feldmann R.N. Maini Cells with dendritic morphology and bright interleukin-1α staining circulate in the blood of patients with rheumatoid arthritis Clin Exp Immunol 80 1990 25 31
10. Bresnihan B. Alvaro-Garcia J.M. Cobby M. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthritis Rheum 1998 (in press)
11. G.V. Campion M.E. Lesback J. Lookabaugh Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis Arthritis Rheum 39 1996 1092 1101
12. A. Cauli G. Yanni G.S. Panayi Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane Br J Rheumatol 36 1997 935 940
13. Chang D.-M. M.E. Weinblatt P.H. Schur The effects of methotrexate on interleukin-1 in patients with rheumatoid arthritis J Rheumatol 19 1992 1678 1682
14. P. Chomarat E. Vannier J. Dechanet Balance of IL-1 receptor antagonist in rheumatoid synovium and its regulation by IL-4 and IL-10 J Immunol 154 1995 1432 1439
15. C.Q. Chu M. Field S. Allard Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair Br J Rheumatol 31 1992 653 661
16. G. Cunnane A. Madigan O. FitzGerald Treatment with recombinant human Interleukin-1 receptor antagonist (rhIL-1ra) may reduce synovial infiltration in rheumatoid arthritis (RA) Arthritis Rheum 39 1996 S245
17. V.A. Danid A.J. Kulesz D.S. Nelson The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: Variation in health subjects and patients with arthritis Clin Exp Immunol 79 1990 335 340
18. B.W. Deleuran C.Q. Chu M. Field Localisation of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis Br J Rheumatol 31 1992 801 809
19. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147
20. C.A. Dinarello S.M. Wolff The role of interleukin-1 in disease N Engl J Med 328 1993 106 113
21. Dingle J.T. Page Thomas D.P. B. King In vivo studies of articular tissue damage mediated by catabolin/interleukin-1 Ann Rheum Dis 46 1987 527 533
22. B. Dulary C.I. Westacott C.J. Elson IL-1 secreting cell assay and its application to cells from patients with rheumatoid arthritis Br J Rheumatol 31 1992 19 24
23. G. Fantuzzi C.A. Dinarello The inflammatory response in IL-1β–deficient mice: Comparison with other cytokine-related knock-out mice J Leukocyte Biol 59 1996 489 493
24. D.T. Felson J.J. Anderson M. Boers The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials Arthritis Rheum 36 1993 729 740
25. G.S. Firestein J.M. Alvaro-Garcia R. Maki Quantitative analysis of cytokine gene expression in rheumatoid arthritis J Immunol 144 1990 3347 3353
26. G.S. Firestein A.E. Berge D.E. Tracey IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium J Immunol 149 1992 1054 1062
27. G.S. Firestein D.L. Boyle C. Yu Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis Arthritis Rheum 37 1994 644 652
28. J.F. Fries P.W. Spitz R.G. Kraines Measurement of patient outcome in arthritis Arthritis Rheum 23 1980 137 145
29. M. Goto M. Fujisawa A. Yamada Spontaneous release of angiotensin converting enzyme and interleukin-1β from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition Ann Rheum Dis 49 1990 172 176
30. E.D. Harris Rheumatoid arthritis: Pathophysiology and implications for therapy N Engl J Med 322 1990 1277 1289
31. B. Henderson R.C. Thompson T. Hardingham Inhibition of interleukin-1 induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist Cytokine 3 1991 246 249
32. I. Holt R.G. Cooper J. Denton Cytokine inter-relationship and their association with disease activity in arthritis Br J Rheumatol 31 1992 725 733
33. Hung G.L. Galea Lauri J. G.M. Mueller Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium Gene Ther 1 1994 64 69
34. C. Jacobs D. Young S. Tyler In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats J Immunol 141 1988 2967 2974
35. L.A.B. Joosten M.M.A. Helsen van de Loo F.A.J. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNFα, anti-IL-1β and IL-1ra Arthritis Rheum 39 1996 797 809
36. P. Kahle J.G. Saal K. Schaudt Determination of cytokines in synovial fluids: Correlation with diagnosis and histomorphological characteristics of synovial tissue Ann Rheum Dis 51 1992 731 734
37. A.E. Koch S.L. Kunkel S.W. Chensue Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages Clin Immunol Immunopathol 64 1992 23 29
38. A. Larsen K. Dale M. Eek Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films Acta Radiol Diagn 18 1977 481 491
39. J. Lewthwaite S.M. Blake T.E. Hardingham The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit J Rheumatol 21 1994 467 472
40. E.J. McDonnell L.A. Hoerrner M.W. Lark Recombinant human interleukin-1β-induced increase in levels of proteoglycans, stromelysin and leukocytes in rabbit synovial fluid Arthritis Rheum 35 1992 799 805
41. M. Malyak R.E. Swaney W.P. Arend Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: Potential contribution from synovial fluid neutrophils Arthritis Rheum 36 1993 781 789
42. S.S. Makarov J.C. Olsen W.N. Johnston Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA Proc Natl Acad Sci U S A 93 1996 402 406
43. L.C. Miller E.A. Lynch S. Isa Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis Lancet 341 1993 146 148
44. D. Mulherin O. FitzGerald B. Bresnihan Synovial tissue macrophage populations and articular damage in rheumatoid arthritis Arthritis Rheum 39 1996 115 124
45. K. Otani I. Nita W. Macauley Suppression of antigen-induced arthritis in rabbits by ex-vivo gene therapy J Immunol 156 1996 3558 3562
46. H.E. Paulus M.J. Egger J.R. Ward Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on findings in patients treated with placebo Arthritis Rheum 33 1990 477 484
47. J.P. Pelletier J.P. Caron C. Evans In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy Arthritis Rheum 40 1997 1012 1919
48. E.R. Pettipher B. Henderson T. Hardingham Cartilage proteoglycan depletion in acute and chronic antigen-induced arthritis Arthritis Rheum 32 1989 601 607
49. E.R. Pettipher B. Henderson S. Moncada Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit Br J Pharmacol 95 1988 169 176
50. E.R. Pettipher G.A. Higgs D. Henderson Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint Proc Natl Acad Sci U S A 83 1986 8749 8753
51. M. Rooney J.A. Symons G.W. Duff Interleukin-1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis Rheumatol Int 10 1990 217 219
52. S. Ruschen W. Tellbery H. Warnatz Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls Clin Exp Immunol 89 1992 32 37
53. J. Saklatvala S.J. Sarsfield Y. Townsend Pig interleukin-1: Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation and fever J Exp Med 162 1985 1208 1222
54. J.H. Schwab S.K. Anderle R.R. Brown Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats Infect Immun 59 1991 4436 4442
55. P. Seckinger J. Klein-Nulend C. Alander Natural and recombinant human IL-1 receptor antagonist block the effects of IL-1 on bone resorption and prostaglandin production J Immunol 145 1990 4181 4184
56. R.J. Smith J.E. Chin L.M. Sam Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion and chondrocyte responsiveness Arthritis Rheum 34 1991 78 83
57. N.D. Staite K.A. Richard D.G. Aspar Induction of acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin Arthritis Rheum 33 1990 253 260
58. S.A. Stimpson F.G. Dalldorf I.G. Otterness Exacerbation of arthritis by IL-1 in rat joints previously injected with peptidoglycan-polysaccharide J Immunol 140 1988 2964
59. R. Thomas G.J. Carroll Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate Arthritis Rheum 36 1993 1244 1252
60. van de Loo F.A.J. O.J. Arntz A.C. Bakker Role of interleukin-1 in antigen-induced exacerbations of murine arthritis Am J Pathol 146 1995 239 249
61. van de Loo F.A.J. L.A.B. Joosten van Lent P.L.E.M. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage, proteoglycan metabolism and destruction: Effect of in situ blocking of murine antigen- and zymosan-induced arthritis Arthritis Rheum 38 1995 164 172
62. van de Loo F.A.J. van den Berg W.B. Effect of murine recombinant interleukin-1 on synovial joints in mice: Measurement of patellar cartilage metabolism and joint inflammation Ann Rheum Dis 49 1990 238 245
63. van Lent P.L.E.M. van de Loo F.A.J. A.E.M. Holthuysen Major role for interleukin-1 but not tumor necrosis factor in early cartilage damage in immune complex arthritis in mice J Rheumatol 22 1995 2250 2258
64. van Lent P.L.E.M. van den Bersselaar L.A.M. van den Hoek A.E.M. Cationic immune complex arthritis in mice: A new model. Synergistic effect of complement and interleukin-1 Am J Pathol 140 1992 1451 1461
65. van Lent P.L.E.M. van den Hoek A.E.M. van den Bersselaar L.A.M. Early cartilage degradation in cationic immune complex arthritis in mice: Relative role of interleukin-1, the polymorphonuclear cell (PMN) and PMN elastase J Rheumatol 21 1994 321 329
66. van den Berg W.B. Lessons for joint destruction from animal models Curr Opin Rheumatol 9 1997 221 228
67. N.C. Wood E. Dickens J.A. Symons In situ hybridisation of interleukin-1 in CD14 positive cells in rheumatoid arthritis Clin Immunol Immunopathol 62 1992 295 300
68. P.H. Wooley J.D. Whalen D.C. Chapman The effect of interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice Arthritis Rheum 36 1993 1305 1314
69. G. Yanni A. Whelan C. Feighery Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration Clin Exp Immunol 93 1993 387 395
70. P.F. Zangerle D. DeGroote M. Lopez Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IFNγ and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis Cytokine 4 1992 568 575